A multicultural group practicing yoga together in a bright studio

Mochi Health vs Yucca Health: GLP-1 Comparison 2026

Mochi Health vs Yucca Health: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 3, 20264 min read

Quick answer

Yucca Health typically wins on sticker price for compounded GLP-1. Choose Yucca Health if you're price-first; choose Mochi Health if you want brand-name (FDA-approved) access and a live video consult.

Side-by-side comparison

Feature	Mochi Health	Yucca Health
Best for	Brand-name access where insurance can apply	Low advertised entry price on compounded GLP-1 with plain FDA disclosures and all-50-state provider coverage
Medication type	Brand-name and compounded GLP-1	Compounded semaglutide and tirzepatide, once-weekly injection ('Semaglutide+' / 'Tirzepatide+'); also sells NAD+ and Sermorelin (out of registry scope)
Pricing model	Membership + medication, sometimes insurance-billed	6-month prescription plans billed monthly/quarterly/6-month; advertised new-patient entry pricing; full pricing shared after intake
Semaglutide price	Membership $79/mo + compounded semaglutide $99/mo (all doses); brand-name billed via insurance	Compounded. Verbatim from tryyucca.com 2026-09-03: 'Semaglutide plans start at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month.' The 6-month rate dropped $146 -> $125; $146 is now the published month-to-month rate. Page still notes 'Pricing is shared after intake once eligibility is confirmed.'
Tirzepatide price	Membership $79/mo + compounded tirzepatide $199/mo (all doses); brand-name billed via insurance	Compounded. Verbatim from tryyucca.com 2026-09-03: 'Tirzepatide plans start at $225 per month with the 6-month plan ($1,350 total); the month-to-month plan is $258 per month.' The 6-month rate dropped $258 -> $225; $258 is now the published month-to-month rate.
Key watchout	Final cost depends heavily on insurance and pharmacy	The $125/mo figure is the 6-month-commitment semaglutide rate ($750 total); month-to-month is $146/mo. Dose-level pricing is still shared only after intake ('Pricing is shared after intake once eligibility is confirmed'), so confirm your dose's rate. Confirm your dose's ongoing rate at intake. Pharmacies are not named.
Price checked	Checked by a person July 3, 2026 · an automated check re-read it September 14, 2026	Checked by a person September 3, 2026 · an automated check re-read it September 14, 2026

When to choose Mochi Health

You want to attempt insurance coverage for brand-name GLP-1
You'd prefer brand Wegovy or Zepbound when feasible
You're OK with a membership fee on top of medication cost
You want a program that won't lock you into compounded only

Check current Mochi Health pricing →

When to choose Yucca Health

You want a low advertised entry price on compounded semaglutide or tirzepatide
You value an upfront 'not FDA-approved' compounding disclosure in the FAQ
You want provider coverage in all 50 states with free 2-day shipping
You're comfortable confirming your exact ongoing rate at intake (pricing beyond the entry offer is shared after eligibility)

Check current Yucca Health pricing →

Full reviews

Frequently asked questions

Is Mochi Health cheaper than Yucca Health?

Mochi Health starts lower on semaglutide (Membership $79/mo + compounded semaglutide $99/mo (all doses); brand-name billed via insurance). Mochi Health starts lower on tirzepatide (Membership $79/mo + compounded tirzepatide $199/mo (all doses); brand-name billed via insurance). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Mochi Health or Yucca Health?

Mochi Health starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Mochi Health and Yucca Health compounded or brand-name?

Mochi Health offers brand-name and compounded glp-1. Yucca Health offers compounded semaglutide and tirzepatide, once-weekly injection ('semaglutide+' / 'tirzepatide+'); also sells nad+ and sermorelin (out of registry scope). If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Mochi Health to Yucca Health?

Yes, switching between Mochi Health and Yucca Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Mochi Health and Yucca Health to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Membership $79/mo + compounded semaglutide $99/mo (all doses); brand-name billed via insurance and Compounded. Verbatim from tryyucca.com 2026-09-03: 'Semaglutide plans start at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month.' The 6-month rate dropped $146 -> $125; $146 is now the published month-to-month rate. Page still notes 'Pricing is shared after intake once eligibility is confirmed.' are starting tiers, not your guaranteed long-term cost.